Publication | Closed Access

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy

Antiangiogenic FactorsSignaling PathwayReceptor Tyrosine KinaseImmunologyDistinct PathwaysTherapeutic EfficacyImmunologic MechanismAutoimmunityHer2-targeted Antibody TherapyImmunotherapyMedicineCell BiologyCell SignalingTumor MicroenvironmentTumor Biology